Conversion and pharmacokinetics profiles of a novel pro-drug of 3-n-butylphthalide, potassium 2-(1-hydroxypentyl)-benzoate, in rats and dogs
Potassium 2-(1-hydroxypentyl)-benzoate (d/-PHPB) is a novel pro-drug of 3-n-butylphthalide (dkNBP) that is used to treat ischemic stroke. Currently, dl-PHPB is in phase II-III clinical trials in China. In this study, we investigated the conversion and pharmacokinetics profiles of dI-PHPB in vitro an...
Saved in:
Published in | 中国药理学报:英文版 Vol. 39; no. 2; pp. 275 - 285 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!